The Magic Formula, as defined by Joel Greenblatt in his book The Little Book that Beats the Market, entails evaluating companies based on two metrics: earnings yield (EBIT/enterprise...
Keep Reading →
February 26 - Hedge Funds, News
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of...
Keep Reading →
February 25 - Hedge Funds, Industries, News
After much suspense, the US Federal Reserve finally began cutting interest rates in late 2024, dropping the federal funds rate by 75 basis points in two cuts in September and ...
Keep Reading →
February 25 - Hedge Funds, News, Retirement
Bourgeon Capital Management LLC is an investment advisory firm headquartered in Darien, Connecticut.
Keep Reading →
February 25 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer recalled the stock market crash due to the coronavirus.
Keep Reading →
February 24 - News
Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development...
Keep Reading →
February 22 - Hedge Funds, News
In this article, we will take a detailed look at the 11 most expensive stocks insiders are buying recently.
Keep Reading →
February 21 - Insider Trading, News
According to Deutsche Bank Wealth Management, the global economy in 2025 is expected to face some tough challenges, with growth forecasts looking modest – the US GDP at 2.0%, ...
Keep Reading →
February 18 - Dividend Stocks, Hedge Funds, News
The stock market had a mixed start to 2025 as the Chinese Deepseek AI model has put the U.S. AI giants on the back foot.
Keep Reading →
February 17 - Hedge Funds, News
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Keep Reading →
February 16 - Hedge Funds, Industries, News
Strong economic growth and the prospect of declining interest rates continue to support gains in global equities.
Keep Reading →
February 15 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on why the flagship S&P index remained stable despite multiple catalysts such as a trade war, DeepSeek...
Keep Reading →
February 15 - News
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
Keep Reading →
February 13 - News, Stock Analysis
In his recent appearance on CNBC's Squawk on the Street, Jim Cramer spent nearly all of the show either discussing stocks or the changed environment for AI data center stocks ...
Keep Reading →
February 11 - News
Investor optimism is still strong despite ongoing economic uncertainties, with analysts highlighting some important factors that are driving market performance.
Keep Reading →
February 10 - Hedge Funds, News
The Dow is a highly recognized and influential stock market index that tracks the performance of 30 publicly traded companies listed on US stock exchanges, representing a wide...
Keep Reading →
February 6 - Dividend Stocks, Hedge Funds, News
Jim Cramer, the host of Mad Money, recently examined the latest market trends, highlighting some important themes where stocks have faced challenges, especially those reliant ...
Keep Reading →
February 6 - Hedge Funds, News
Merck & Co., Inc. (NYSE:MRK) Q4 2024 Earnings Call Transcript February 4, 2025Merck & Co., Inc. misses on earnings expectations.
Keep Reading →
February 5 - News, Transcripts
In recent years, many investors have shifted their focus from dividend-paying stocks to high-growth secular-themed stocks that typically don’t offer dividends.
Keep Reading →
February 5 - Hedge Funds, News
MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 billion.
Keep Reading →
February 4 - Market Movers, News
Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which will be dominated by earnings reports from various ...
Keep Reading →
February 3 - Hedge Funds, News
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
Keep Reading →
February 2 - Hedge Funds, News
The start of 2020 marked a turning point for retail trading, driven by increased market volatility, stay-at-home orders, and commission-free trading across platforms, which led...
Keep Reading →
January 31 - Dividend Stocks, Hedge Funds, News
In the episode of CNBC's Squawk on the Street aired on the day of the DeepSeek stock market selloff, Jim Cramer mentioned the risks that utility companies had talked to him about...
Keep Reading →
January 29 - News
Blue chip stocks have long been considered the gold standard of investments, offering a combination of steady growth, consistent dividends, and a reputation for weathering economic...
Keep Reading →
January 29 - Hedge Funds, News
Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth potential, and ability to provide steady income through...
Keep Reading →
January 28 - Hedge Funds, News
Television personality, financier, and entrepreneur, Kevin O'Leary, also known as 'Mr.
Keep Reading →
January 27 - Hedge Funds, News
The US stocks ended 2024 with a healthy Q4, as the equity markets were primarily aided by solid economic growth, healthy earnings momentum, and the expectations of the rate cuts...
Keep Reading →
January 26 - Hedge Funds, News
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer had a lot to say about a lot of stocks.
Keep Reading →
January 23 - News
The Dow Jones Industrial Average is among the most popular stock market indices globally.
Keep Reading →
January 23 - Hedge Funds, News
Prem Watsa is a Canadian billionaire, entrepreneur, and investor often referred to as the Canadian Warren Buffett for his value-based investment approach and long-term focus.
Keep Reading →
January 22 - Hedge Funds, News
The market outlook is as uncertain as it gets.
Keep Reading →
January 21 - Hedge Funds, News
Dividend stocks, while popular among investors, have been underperforming for a while.
Keep Reading →
January 21 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’ Substack by Magnus Ofstad.
Keep Reading →
January 20 - News, Stock Analysis
Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus on the growth prospects of certain pharmaceutical stocks while...
Keep Reading →
January 18 - Hedge Funds, News
The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling a potential cooling in inflation pressures.
Keep Reading →
January 18 - Hedge Funds, News
The Dow Jones Industrial Average, or simply the Dow, is one of the most well-known and influential stock market indices globally.
Keep Reading →
January 16 - Dividend Stocks, Hedge Funds, News
In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release.
Keep Reading →
January 15 - News
In a recent episode of CNBC's Squawk On The Street, Jim Cramer started out by commenting on quantum computing stocks.
Keep Reading →
January 14 - News
The year 2024 proved favorable for dividends, even though the Dividend Aristocrats Index lagged behind the broader market.
Keep Reading →
January 12 - Dividend Stocks, Hedge Funds, News
In his appearance on Squawk on the Street the day CES took place in Las Vegas, Jim Cramer commented on the stock market division that persisted throughout 2024 and is present ...
Keep Reading →
January 10 - News
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions...
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
The market has shown strong performance overall, with the S&P 500 up nearly 26% year to date. However, in the past thirty days, it has experienced a slight decline of 1%.
Keep Reading →
December 30 - Hedge Funds, News
Equity market pricing is never perfect due to supply and demand imbalances, emotional reactions, and errors.
Keep Reading →
December 26 - Hedge Funds, News
The stock market appears poised for another year of impressive returns, likely extending into 2025. However, concerns about high valuations persist.
Keep Reading →
December 19 - Hedge Funds, News
Merck has partnered with Hansoh, a Chinese biopharmaceutical company, for a global licensing deal to develop an oral GLP-1 receptor agonist for the treatment of conditions related...
Keep Reading →
December 18 - News, Stock Analysis
Dividend-focused investors are often drawn to stocks with high yields, shaping their strategies around acquiring such investments.
Keep Reading →
December 17 - Dividend Stocks, Hedge Funds, News
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Keep Reading →
December 14 - Hedge Funds, News
The US economy expanded by 2.8% in the third quarter of 2024, as reported in the Advance GDP release from the U.S. Bureau of Economic Analysis.
Keep Reading →
December 10 - Dividend Stocks, Hedge Funds, News
Stocks in the United States are rallying high, but some strategists are eyeing a few risks.
Keep Reading →
December 6 - Hedge Funds, News